Deutsch English Français

Contact

EP1294896

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1294896

EP1294896 - 13295 NOVEL PROTEIN KINASE MOLECULES AND USES THEREFOR [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 19.11.2004 Database last updated on 04.11.2024
Most recent event Tooltip	19.11.2004	Application deemed to be withdrawn	published on 05.01.2005 [2005/01]
Applicant(s)	For all designated states MILLENNIUM PHARMACEUTICALS, INC. 640 Memorial Drive Cambridge, MA 02139-4815 / US
	[N/P]
Former [2003/13]	For all designated states Millennium Pharmaceuticals, Inc. 640 Memorial Drive Cambridge, MA 02139-4815 / US
Inventor(s)	01 / MEYERS, Rachel 115 Devonshire Road Newton, MA 02468 / US
	02 / WILLIAMSON, Mark 15 Stonecrest Drive Saugus, MA 01906 / US
	[2003/13]
Representative(s)	Hall, Robert Leonard, et al Harrison Goddard Foote Fountain Precinct Balm Green Sheffield S1 2JA / GB
	[N/P]
Former [2003/13]	Hall, Robert Leonard, et al Harrison Goddard Foote, Fountain Precinct, Leopold Street Sheffield S1 2QD / GB
Application number, filing date	01928963.6	25.04.2001
	[2003/13]
	WO2001US13783
Priority number, date	US20000199391P	25.04.2000 Original published format: US 199391 P
	US20000596071	16.06.2000 Original published format: US 596071
	[2003/13]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO0181558
	Date:	01.11.2001
	Language:	EN
	[2001/44]
	Type:	A2 Application without search report
	No.:	EP1294896
	Date:	26.03.2003
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 01.11.2001 takes the place of the publication of the European patent application.
	[2003/13]
Search report(s)	International search report - published on:	EP	11.04.2002
Classification	IPC:	C12N15/54, C12N9/12, C07K16/40, C12Q1/68, G01N33/573, A61K38/00, A61K31/7088	[2003/13]
	CPC:	C12N9/1205 (EP,US); A61K38/00 (EP,US)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/13]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
	RO	Not yet paid
	SI	Not yet paid
Title	German:	13295 PROTEINKINASE MOLEKÜLE UND DEREN VERWENDUNG	[2003/13]
	English:	13295 NOVEL PROTEIN KINASE MOLECULES AND USES THEREFOR	[2003/13]
	French:	NOUVELLES MOLECULES 13295 DE PROTEINE KINASE ET LEURS UTILISATIONS	[2003/13]
Biological material	This application mentions deposited biological material, check the file for details
Entry into regional phase	22.11.2002	National basic fee paid
	22.11.2002	Designation fee(s) paid
	22.11.2002	Examination fee paid
Examination procedure	21.09.2001	Request for preliminary examination filed International Preliminary Examining Authority: EP
	22.11.2002	Examination requested [2003/13]
	22.12.2003	Despatch of a communication from the examining division (Time limit: M06)
	02.06.2004	Application deemed to be withdrawn, date of legal effect [2005/01]
	06.08.2004	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2005/01]
Fees paid	Renewal fee
	07.04.2003	Renewal fee patent year 03
	Penalty fee
	Additional fee for renewal fee
	30.04.2004	04 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[A]WO9613592 (MAX PLANCK GESELLSCHAFT [DE], et al);
		[PX]WO0073469 (SUGEN INC [US], et al) [PX] 1-24 * the whole document *;
		[E]WO0136645 (CURAGEN CORP [US], et al) [E] 1-24* the whole document *;
		[E]WO0138503 (SUGEN INC [US], et al) [E] 1-24 * the whole document *;
		[E]WO0146397 (INCYTE GENOMICS INC [US], et al) [E] 1-24 * the whole document *;
		[E]WO0183768 (MERCK PATENT GMBH [DE], et al) [E] 1-24 * the whole document *;
		[X] - NCI-CGAP, "National Cancer Institute, Cancer Genome Anatomy Project (CGAP), Tumor Gene Index http://www.ncbi.nlm.nih.gov/ncicgap", EMBL SEQUENCE LIBRARY, (19980810), XP002185790 [X] 1,2,4 * accession no. AI075923 *
		[PX] - NCI-CGAP, "National Cancer Institute, Cancer Genome Anatomy Project (CGAP), Tumor Gene Index http://www.ncbi.nlm.nih.gov/ncicgap; TESTIS-SPECIFIC SERINE/THREONINE KINASE", EMBL SEQUENCE LIBRARY, (20000811), XP002185791 [PX] 1,2,4 * accession no. BE551971 *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p